Last month the agency said it had begun examining Medicare claims data to look for potential fraud in ordering of SARS-CoV-2 testing and related tests.
William Hughes, the owner and operator of the Greensburg, Pennsylvania-based lab, made cash payments for referrals between October 2011 and August 2013.
The agency said it believes its recent focus on the issue has tamped down on genetic testing fraud, though it expects new questionable arrangements will emerge.
The owner is accused of falsely billing Medicare for cancer genomic testing and pharmacogenetic testing that regularly exceeded $12,000 per beneficiary.
Three executives from Northwest Physicians have been indicted while an executive with Molecular Testing Labs pleaded guilty for his part in the alleged scheme.
